India considers exempting from local drug trials medicines for life threatening diseases that have been approved abroadBMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g5583 (Published 10 September 2014) Cite this as: BMJ 2014;349:g5583
- Sanjeet Bagcchi
The Indian government is considering exempting some important drugs, which have been approved in clinical trials abroad, from being tested in local clinical trials.
Media reports said that the government had decided to prepare a list of serious and life threatening diseases specifically relevant to India and to consider exempting new drugs for such diseases and ailments from local clinical trials if they have already been approved for marketing in developed countries such as the United States, the United Kingdom, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial